Skip to content

Zeina Ali

NPI 1285976662ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Palm Springs, CA

Internal Medicine, Endocrinology, Diabetes & Metabolism in Palm Springs, California, licensed in CA, with an NPI issued in March 2013. Part D covered 2,105 prescriptions written in 2024, 61% of them generic. Amgen Inc. was the largest of 2 companies reporting payments in 2025, $70.35 in all, mostly food and beverage.

Overview

NPI1285976662
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedMar 22, 2013
Last updated in NPPESAug 3, 2023
Certified by providerAug 3, 2023

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)2,105 · 5,526 30-day fills
Patients456
Total drug cost$439,606
Generic share61% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$70.35 · 3 payments from 2 companies
  • 2024$74.98 · 4 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Amgen Inc.$43.362
Medtronic, Inc.$26.991

What the 2025 payments were for

  • Food and Beverage$70.35 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Palm Springs

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →